Literature DB >> 10094406

A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity.

R Lin1, J Hiscott.   

Abstract

The Interferon Regulatory Factors (IRFS) play an important role in the transcriptional control of growth regulatory and immunoregulatory genes. The inducibility and availability of IRF-1 and IRF-2 are influenced by external stimuli, such as virus infection or interferon treatment. In the present study, we sought to examine the potential modulatory role of phosphorylation on IRF-1 transcriptional activity. During the purification of IRF recombinant proteins, a kinase activity copurified with IRF-1 (and IRF-2) from baculovirus infected Sf9 insect cell extracts, but not from E. coli extracts. The kinase activity was also identified in Jurkat T cells, specifically interacted with IRF proteins in GST affinity chromatography, and phosphorylated IRF-1 with high specificity in vitro. Using an in gel kinase assay with recombinant IRF-1 as substrate, two molecular weight forms of the kinase (43 and 38 kDa) were identified. Biochemical criteria identified the kinase activity as the alpha catalytic subunit of casein kinase II (CKII). Furthermore, far western analysis of protein-protein interactions demonstrated that casein kinase II directly interacted with IRF-1 protein. Deletion mutation analysis of IRF-1 revealed that IRF-1 was phosphorylated at two clustered sites, one located between amino acids 138-150, the other in the C-terminal acidic activation domain between amino acids 219-231. Cotransfection studies comparing wild type and point mutated forms of IRF-1 demonstrated that mutations of the four phosphoaceptor residues in the C-terminal transactivation domain, significantly decreased transactivation by IRF-1, indicating that casein kinase II may be involved in the regulation of IRF-1 function. Strikingly, the casein kinase II clusters in IRF-1 resemble the sites identified in the C-terminal PEST domain of IkappaBalpha. The present experiments, together with previously published studies with IkappaBalpha, c-Jun and other proteins, indicate a broad role for casein kinase II phosphorylation in the regulation of transcription factor activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10094406

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  63 in total

Review 1.  Casein kinase 2: an 'eminence grise' in cellular regulation?

Authors:  L A Pinna
Journal:  Biochim Biophys Acta       Date:  1990-09-24

2.  Induction of endogenous IFN-alpha and IFN-beta genes by a regulatory transcription factor, IRF-1.

Authors:  T Fujita; Y Kimura; M Miyamoto; E L Barsoumian; T Taniguchi
Journal:  Nature       Date:  1989-01-19       Impact factor: 49.962

3.  Casein kinase II phosphorylates I kappa B alpha at S-283, S-289, S-293, and T-291 and is required for its degradation.

Authors:  J A McElhinny; S A Trushin; G D Bren; N Chester; C V Paya
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

4.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

Authors:  Z Chen; J Hagler; V J Palombella; F Melandri; D Scherer; D Ballard; T Maniatis
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

5.  Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain.

Authors:  M Hibi; A Lin; T Smeal; A Minden; M Karin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

Review 6.  Function and activation of NF-kappa B in the immune system.

Authors:  P A Baeuerle; T Henkel
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

8.  Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.

Authors:  H Harada; M Kitagawa; N Tanaka; H Yamamoto; K Harada; M Ishihara; T Taniguchi
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

9.  Characterization of the DNA binding domain of the mouse IRF-2 protein.

Authors:  K Uegaki; M Shirakawa; T Fujita; T Taniguchi; Y Kyogoku
Journal:  Protein Eng       Date:  1993-02

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  29 in total

1.  Retinoic acid exerts dual regulatory actions on the expression and nuclear localization of interferon regulatory factor-1.

Authors:  Xin M Luo; A Catharine Ross
Journal:  Exp Biol Med (Maywood)       Date:  2006-05

2.  A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3.

Authors:  Alexa C Robitaille; Mélissa K Mariani; Audray Fortin; Nathalie Grandvaux
Journal:  J Vis Exp       Date:  2016-01-24       Impact factor: 1.355

3.  Anaplasma phagocytophilum modulates gp91phox gene expression through altered interferon regulatory factor 1 and PU.1 levels and binding of CCAAT displacement protein.

Authors:  Venetta Thomas; Swapna Samanta; Caiyun Wu; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 4.  Protein kinase CK2, an important regulator of the inflammatory response?

Authors:  Nishi N Singh; Dipak P Ramji
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

Review 5.  Glucocorticoid and cytokine crosstalk: Feedback, feedforward, and co-regulatory interactions determine repression or resistance.

Authors:  Robert Newton; Suharsh Shah; Mohammed O Altonsy; Antony N Gerber
Journal:  J Biol Chem       Date:  2017-03-10       Impact factor: 5.157

6.  Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.

Authors:  Zhihua Ren; Yan Wang; Duan Tao; David Liebenson; Thomas Liggett; Rajendra Goswami; Robert Clarke; Dusan Stefoski; Roumen Balabanov
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

7.  IκB kinase ε targets interferon regulatory factor 1 in activated T lymphocytes.

Authors:  Marco Sgarbanti; Giulia Marsili; Anna Lisa Remoli; Emilia Stellacci; Antonello Mai; Dante Rotili; Edvige Perrotti; Chiara Acchioni; Roberto Orsatti; Nunzio Iraci; Mathieu Ferrari; Alessandra Borsetti; John Hiscott; Angela Battistini
Journal:  Mol Cell Biol       Date:  2014-01-06       Impact factor: 4.272

8.  Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.

Authors:  Jianhua Liu; Celine C Berthier; J Michelle Kahlenberg
Journal:  Arthritis Rheumatol       Date:  2017-08-08       Impact factor: 10.995

9.  Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

Authors:  Ena Wang; Lance D Miller; Galen A Ohnmacht; Simone Mocellin; Ainhoa Perez-Diez; David Petersen; Yingdong Zhao; Richard Simon; John I Powell; Esther Asaki; H Richard Alexander; Paul H Duray; Meenhard Herlyn; Nicholas P Restifo; Edison T Liu; Steven A Rosenberg; Francesco M Marincola
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

10.  Francisella tularensis SchuS4 and SchuS4 lipids inhibit IL-12p40 in primary human dendritic cells by inhibition of IRF1 and IRF8.

Authors:  Robin Ireland; Rong Wang; Joshua B Alinger; Pamela Small; Catharine M Bosio
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.